Approval · Notice of Compliance 34865 · 2025
ACTIVELLE: Notice of Compliance 34865
Issued February 17, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34865
- Date
- February 17, 2025
- Company
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template. Update to Patient Medication Information.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTIVELLE | Not yet assigned | — |
| ACTIVELLE LD | Not yet assigned | — |
Medicinal ingredients
- ESTRADIOL 1.03 MG per TAB
- NORETHINDRONE ACETATE 0.5 MG per TAB
- ESTRADIOL 0.517 MG per TAB
- NORETHINDRONE ACETATE 0.1 MG per TAB